In addition, in individuals with cancer, treatment with high doses of the T cell cytokine IL-2 induces a cluster of mood and cognitive symptoms, overlapping with MDD [46] and the depressive symptoms observed in our study, in up to 60% of treated individuals, depending on the dose and modality of treatment [47]–[49]. Here, IL2 is linked to major depressive disorder.